STAT

Opinion: Digital therapeutics vs. digital care: defining the landscape

How do we categorize digital health, an increasingly large, crowded, and diverse field? If you have an answer, please weigh in.

The conversations I had at this year’s J.P. Morgan Healthcare Conference were a microcosm of a dominant narrative coming out of one of the industry’s most influential weeks: How do we categorize digital health, an increasingly large, crowded, and diverse field?

“Digital health” is an umbrella term that’s grown to include everything from electronic health records to wellness apps and clinically validated therapeutic interventions that mirror or improve upon existing in-person therapies. It’s an area of intense interest and investment. But it is also a space in which many of the investors who have committed billions are still seeking clarity as to how the puzzle of diffuse digital health offerings fit together.

As the co-founder and CEO of Omada Health, I’ve had the opportunity to play a role over the last eight years defining this growing space into subcategories with true meaning. More than five years ago, Omada at a time

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Moderna Covid-flu Vaccine, A Paused Pfizer Study, And More
Moderna announced its combination Covid and flu vaccine generated stronger immune responses in older adults in a Phase 3 trial than individual vaccines.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Novo’s Wegovy Approval In China, A Merck KGaA Cancer Trial Failure, And More
Novo Nordisk's weight loss drug Wegovy has been approved in China, the country estimated to have the highest number of overweight or obese people.
STAT1 min readIntelligence (AI) & Semantics
STAT+: Q&A: Defining Responsible AI In Health Care, With CHAI CEO Brian Anderson
CHAI CEO Anderson wants to build public trust in AI and empower patients and providers to have more informed conversations.

Related